Okay, let's tackle this question. The user is asking about an alpha-1 blocker used for BPH (Benign Prostatic Hyperplasia) that doesn't affect blood pressure. First, I need to recall the different alpha-1 blockers and their selectivity.

Alpha-1 blockers work by relaxing smooth muscle in the prostate and bladder neck, which helps with BPH symptoms. But some of these drugs also cause systemic vasodilation, leading to a drop in blood pressure. The key here is to identify which alpha-1 blocker is more selective for the prostate and thus has less effect on systemic blood pressure.

Common alpha-1 blockers include tamsulosin, alfuzosin, doxazosin, and terazosin. Doxazosin and terazosin are non-selective and can lower blood pressure, often used for hypertension. Tamsulosin and alfuzosin are more selective for alpha-1A receptors in the prostate, which are responsible for bladder outlet obstruction. This selectivity means they have less systemic effect on blood pressure.

So the correct answer should be tamsulosin or alfuzosin. The question specifies "without any effect on blood pressure," but in reality, all these drugs can cause some hypotension, though tamsulosin is less likely. However, tamsulosin is the most selective, making it the best choice here.

Now, looking at the options (even though they're missing labels), the correct answer is likely tamsulosin. The wrong options would be the non-selective ones like doxazosin and terazosin, which do affect blood pressure. Alfuzosin is also selective but less commonly used compared to tamsulosin. So the answer is tamsulosin.

**Core Concept** Alpha-1 adrenergic receptors in the prostate (alpha-1A subtype) mediate bladder outlet obstruction in BPH. Selective alpha-1A antagonists relieve lower urinary tract symptoms without significant systemic hypotension due to minimal interaction with vascular alpha-1B/D receptors.

**Why the Correct Answer is Right** **Tamsulosin** is an alpha-1A-selective antagonist with high affinity for prostate and bladder neck receptors. It spares vascular alpha-1B/D receptors, minimizing systemic vasodilation. Its unique pharmacophore allows receptor subtype selectivity, making it the preferred first-line alpha-blocker for BPH with minimal cardiovascular side effects.

**Why Each Wrong Option is Incorrect**
**Option A: Doxazosin** – Non-selective alpha-1 blocker with strong vascular effects; causes significant hypotension.
**Option B: Terazosin** – Non-selective alpha-1 blocker used for hypertension; systemic hypotension is common.
**Option C: Prazosin** – Non-selective alpha-1 blocker with potent vasodilatory effects; classic for postural hypotension.

**Clinical Pearl** Remember **"TAMS" (Tamsulosin)** for BPH – it's the only alpha-blocker with prostate-specific selectivity. Non-selective agents (e.g., doxazosin) are contraindicated in hypotensive patients. Always check if the question implies cardiovascular safety as a key differentiator.

**Correct Answer: B. Tamsulosin**

✓ Correct Answer: A. Tamsolusin